TEACHABLE MEDICAL NEWS

CREATED BY ELEASYS LLC

Tag: cytokine storm

How could the antiproliferative drug Jakafi help us defeat the SARS-CoV-2 coronavirus?

By

On May 7, 2020

In cardiovascular system, lymphatic and immune system, respiratory system

TeachableMedicalNews article 05072020

Teachable moment in classrooms:

  1. blood chapter – white blood cell types and their functions
  2. blood chapter – hematopoiesis in red bone marrow
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the anti-proliferative drug Jakafi help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the anti-proliferative drug will be evaluated as potential treatment of SARS-CoV-2 infected patients:

Incyte drug could be part of COVID-19 treatment

A global biopharmaceutical company based in Delaware is working to get one of its drugs approved to treat the new coronavirus disease. Officials at Incyte…

The news item mentions that the drug may inhibit cytokine storm in coronavirus infected patients.

Read More

How could the drug Opaganib help us defeat the SARS-CoV-2 coronavirus?

By

On May 2, 2020

In cardiovascular system, cellular basis of life, lymphatic and immune system, respiratory system

TeachableMedicalNews article 05022020

Teachable moment in classrooms:

  1. cellular basis of life chapter – cell cycle and mitosis
  2. blood chapter – white blood cell types and their functions
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the drug Opaganib help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the investigational drug Opaganib will be evaluated as potential treatment of SARS-CoV-2 infected patients:

https://www.timesofisrael.com/2-israeli-covid-19-patients-improve-in-experimental-drug-trial/

The news item mentions that the drug has an anti-inflammatory effect, and that it is a sphingosine kinase inhibitor.

Read More

How could the leukemia fighter drug Calquence help us defeat the SARS-CoV-2 coronavirus?

By

On April 24, 2020

In cardiovascular system, lymphatic and immune system, respiratory system

TeachableMedicalNews article 04242020

Teachable moment in classrooms:

  1. blood chapter – white blood cell types and their functions
  2. blood chapter – malfunctioning mechanisms in leukemia
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the leukemia fighter drug Calquence help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the anti-cancer drug will be evaluated as potential treatment of SARS-CoV-2 infected patients:

AstraZeneca to test impact of cancer drug Calquence on coronavirus patients

Calquence (acalabrutinib) belongs to a class of drugs called Bruton’s tyrosine kinase (BTK) inhibitors which can suppress autoimmune diseases. The drug, which is currently used to treat certain types of blood cancers, has already been approved for the treatment of adult patients with chronic lymphocytic leukaemia in the U.S.

The news item mentions cytokine storm in coronavirus infected patients, and that the drug is a BTK inhibitor.

Read More

Powered by WordPress & Theme by Anders Norén